AstraZeneca PLC is 615.8x more valuable than Evotec SE by market capitalization ($286.27 B vs $464.89 M). Every figure below comes from audited SEC filings and refreshed market data.
| Metric | EVO | AZN |
|---|---|---|
| Market cap | $464.89 M | $286.27 B |
| US-listed rank | #2673 | #45 |
| SEC filings | 180 | 1,004 |
AstraZeneca PLC is 615.8x more valuable than Evotec SE by market capitalization ($286.27 B vs $464.89 M).
Full pages: Evotec SE and AstraZeneca PLC, or browse the full rankings.